Endothelial apoptosis induced by oxidative stress through activation of NF-κB -: Antiapoptotic effect of antioxidant agents on endothelial cells

被引:210
作者
Aoki, M
Nata, T
Morishita, R
Matsushita, H
Nakagami, H
Yamamoto, K
Yamazaki, K
Nakabayashi, M
Ogihara, T
Kaneda, Y
机构
[1] Osaka Univ, Sch Med, Div Gene Therapy Sci, Suita, Osaka 565, Japan
[2] Osaka Univ, Sch Med, Dept Geriatr Med, Suita, Osaka 565, Japan
关键词
hypoxia; apoptosis; endothelium-derived factors; bax;
D O I
10.1161/01.HYP.38.1.48
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Injury of endothelial cells has been assumed to be an initial trigger of the development or atherosclerosis. In this study, we investigated the molecular mechanisms of endothelial cell death induced by hypoxia, which leads to oxidative stress. To study the relation between hypoxia-induced cell death and activation of nuclear factor-kappaB (NF-kappaB) in a hypoxic state, we evaluated the effect of 2 antioxidant drugs, probucol and pyrrolidine dithiocarbamate (PDTC), on human endothelial apoptosis. Although hypoxic treatment of human aortic endothelial cells resulted in a significant decrease in cell number and a significant increase in apoptotic cells compared with that of cells under normoxia (P <0.01), treatment with probucol (50 mu mol/L) or PDTC (100 mu mol/L) significantly attenuated the decrease in cell number (P <0.01) and was accompanied by inhibition of NF-kappaB activation. Furthermore, downregulation of bcl-2 caused by hypoxia was inhibited by these drugs. We further investigated the translocation of bax protein from the cytoplasm to the mitochondrial heavy fraction membrane, as translocation of bax protein is considered to be a determinant of apoptosis. Interestingly, we found that antioxidant treatment inhibited the translocation of bax protein caused by hypoxia. Moreover, upregulation of p53, a proapoptotic molecule, was observed in hypoxia, whereas treatment with probucol attenuated the expression of p53 accompanied by suppression of NF-kappaB activation. These data suggest functional links between p53 and endothelial apoptosis through the activation of NF-kappaB. Overall, the current study demonstrated that oxidative stress induced apoptosis in human aortic endothelial cells through the downregulation of bcl-2, translocation of bax, and upregulation of p53, probably through NF-kappaB activation. Oxidative stress may play an important role in endothelial apoptosis mediated by hypoxia, through the activation of NF-kappaB.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 57 条
[1]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[2]  
Aoki M, 1997, HEART VESSELS, P71
[3]   Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells - Potential role of p53 in regulation of vascular smooth muscle cell growth [J].
Aoki, M ;
Morishita, R ;
Matsushita, H ;
Hayashi, S ;
Nakagami, H ;
Yamamoto, K ;
Moriguchi, A ;
Kaneda, Y ;
Higaki, J ;
Ogihara, T .
HYPERTENSION, 1999, 34 (02) :192-200
[4]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[5]   GROWTH-FACTOR INDUCED MODULATION OF ENDOTHELIN-1 BINDING TO HUMAN SMOOTH-MUSCLE CELLS [J].
BONIN, PD ;
LEADLEY, RJ ;
ERICKSON, LA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S125-S127
[6]   INHIBITION OF HYPERCHOLESTEROLEMIA-INDUCED ATHEROSCLEROSIS IN THE NONHUMAN PRIMATE BY PROBUCOL .2. CELLULAR COMPOSITION AND PROLIFERATION [J].
CHANG, MY ;
SASAHARA, M ;
CHAIT, A ;
RAINES, EW ;
ROSS, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (10) :1631-1640
[7]   Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium [J].
D'Agnillo, F ;
Wood, F ;
Porras, C ;
Macdonald, VW ;
Alayash, AI .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2000, 1495 (02) :150-159
[8]  
Dulak J, 1999, POL J PHARMACOL, V51, P233
[9]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[10]  
GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431